Source link : https://www.newshealth.biz/health-news/fda-adds-warning-to-osteoporosis-drug-for-hypocalcemia-risk/
The US Food and Drug Administration (FDA) has added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) about increased risk for severe hypocalcemia in patients with advanced chronic kidney disease (CKD). Denosumab is a monoclonal antibody, indicated for the treatment of postmenopausal women with osteoporosis who are at increased risk for […]
Author : News Health
Publish date : 2024-01-19 20:56:41
Copyright for syndicated content belongs to the linked Source.